Why Attend?

Neuroendocrine tumor (NET) disease is both rare and complex. About 15,000 new patients are diagnosed each year in the U.S. – which means that many medical professionals will only encounter neuroendocrine tumors a few times in their careers. With new research, technologies and practices emerging, the landscape
of NET treatment is rapidly changing.
  • The support we provide to medical professionals is crucial to successful treatment and management of NET disease patients. This yearly conference is the premier opportunity to share in the growing knowledge of NET disease treatment – and interact with medical professionals on the front lines of the disease.
  • Over the course of three days, you and your peers will be privy to the latest in NET research, diagnostic techniques, treatment options and best patient practices.
  • This highly interactive gathering will also grant you the ability to share your unique NET insights, research and experiences.
This website contains information on what you’ll find at the conference. With your participation, we will further the cause of NET disease management and treatment in an ever-changing medical world.


SYMPOSIUM GOAL

The NANETS Annual Symposium provides a forum for members of the professional neuroendocrine community to come together to discuss new diagnostic and therapeutic techniques, optimal multidisciplinary care, and the future of neuroendocrine tumor research.
ABOUT NANETS

We at NANETS are a society of over 400 multidisciplinary medical professionals committed to the support of our colleagues in treating NET patients, as well as furthering the cause of NET science and education in North America. NANETS supports the medical community via education, grants and scholarships to up-and-coming medical professionals responsible for advancing NET research and treatment. NANETS is also the only organization in the U.S. that offers a comprehensive education program focused on NET disease.


Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and the North American Neuroendocrine Tumor Society. The University of Texas MD Anderson Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.
 
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 15.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Educational Objectives
 
After participating in the activity, the participant should be able to:
  • Interpret the strengths and weaknesses of recent and ongoing clinical trials (knowledge, competence).
  • Provide updated research on NETs diagnosis and treatment (knowledge).
  • Utilize Interventional Oncology and Nuclear Medicine where appropriate to improve patient care & outcomes (knowledge, competence, performance, patient outcomes).
  • Incorporate recently approved treatments into a patient treatment plan (knowledge, competence, performance, patient outcomes).
  • Formulate a comprehensive career plan for early career clinicians that integrates clinical, research, and practical aspects (knowledge, competence).
  • Apply recent findings in diagnostic and treatment of NETS to your practice and/or research (knowledge, competence).
  • Identify different modalities of diagnosis and treatment of NETS that will result in improved patient outcomes (knowledge).
  • Compare the strengths and weaknesses of the diagnosis and treatment options for Lung NETS (knowledge, competence).
  • Compare the strengths and weaknesses of the diagnosis and treatment options for GI/pNETS (knowledge, competence).
  • Compare the strengths and weaknesses of the diagnosis and treatment options for Pheochromocytoma & Paraganglioma (knowledge, competence).

 

NANETS 2017 Neuroendocrine Symposium Allied Health Program

TARGET AUDIENCE

This program has been designed to meet the educational needs of nurses, nurse practitioners and other health professionals from a variety of settings and levels to include the specialties of oncology, endocrinology, surgery, pathology, internal medicine, gastroenterology, nuclear medicine, interventional and diagnostic radiology, pulmonology, research and primary care.
 

LEARNING OBJECTIVES

Upon completion of the educational activity, participants should be able to:
 
  • Identify the challenges of delivering a well-coordinated, patient-centered cancer care in a complex modern healthcare system
  • Describe the role of information technology (IT) advances to help both providers and patients
  • Explain how patient data, provider and patient involvement, and informatics innovations can support high-quality cancer care
  • Describe the role of an oncology nurse navigator
  • Discuss definition and classification of NETs
  • Identify epidemiological trends in pts with NETs 
  • Discuss surgical interventions
  • Describe the various processes employed by the pathology staff in slide preparation
  • Discuss the importance of quality controls in the pathology setting
  • Describe the fundamentals of external vs internal radiotherapy 
  • Discuss the recent technological innovations in external beam radiotherapy with photons vs particle beams
  • Define indications and outcomes for external beam radiotherapy in neuroendocrine malignancies
  • Describe the nursing implications involved with MIBG therapy 
  • iDescribe the background about complementary, alternative, and integrative medicine
  • Discuss ways to improve patient’s quality of life and relieve stress 
  • Identify strategies for maximizing support and emotional well being 
  • Review the incidence and prevalence GI tract Neuroendocrine Malignancies
  • Review the clinical presentation(s) of GI tract Neuroendocrine Malignancies
  • Discuss the treatment options for GI tract Neuroendocrine Malignancies 
  • Describe intricacies in working with various NET specimen
  • Describe the role of palliative care in patients with NETs 
  • Discuss how and when to incorporate palliative care planning into treatment plan
  • Discuss different treatment modalities for hepatic metastases
  • Review signs and symptoms of post-embolization syndrome
  • Evaluate different research studies involving liver directed therapy
  • Define the clinical features of MEN1
  • Discuss the team based approach required for caring for patients with MEN1
  • Examine the psychological impact of having a hereditary cancer syndrome such as MEN1
  • Describe the difficulties with diagnosing pheochromocytomas and paragangliomas
  • Discuss the need for a multidisciplinary team approach in caring for individuals with these tumors
  • Describe the importance of genetic testing for both individuals and their families
  • Determine the role of a genetic counselor in providing care to patients with NETs 
  • Describe genetic syndromes associated with NETs and indications for referral to genetics 
  • Utilize case examples to illustrate the impact of appropriate genetic diagnoses 
  • Describe diet and nutrition related factors that lead to intestinal malabsorption
  • Describe, nutritional, enzyme and vitamin support 
  • Help define survivorship in NET patients
  • List some components of survivorship care including a Cancer Treatment Summary and Survivorship Care Plan
  • Incorporate ways to survivorship care in clinical practice
  • Define what is a SSA
  • Differentiate side effects of SSA vs disease
  • Identify nursing implications when caring for a patient on SSA’s

 

CE CREDIT PROVIDED by AKH Inc., Advancing Knowledge in Healthcare

Nurse Practitioners AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This program is accredited for 6 contact hour(s) which includes 0 hour(s) of pharmacology.  Program ID #21786.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard
 
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and the North American Neuroendocrine Tumor Society
 

CRITERIA FOR SUCCESS

Statements of credit will be awarded based on the participant's attendance and submission of activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at http://akhcme.com/akhcme/pages/nanets. You must participate in the entire activity to receive credit. There if you have questions about this CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.

 

COMMERCIAL SUPPORT

Full notification of commercial support will be provided in the final course syllabus.
 
Please contact NANETS at staff@nanets.net or (650) 762-6387 for more information.